PublicWire | Emerging Market Stock News
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
No Result
View All Result
PublicWire
No Result
View All Result

Home » Medical » California to ban insurance companies from requiring prescription to cover HIV prevention drugs

Photo by Simone van der Koelen on Unsplash

Photo by Simone van der Koelen on Unsplash

California to ban insurance companies from requiring prescription to cover HIV prevention drugs

by PublicWire
October 9, 2019
in Medical
Reading Time: 2 mins read
0

California is set to become the first state in the United States to allow patients to purchase HIV prevention drugs like pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) over-the-counter and without the prescription from a physician. Furthermore, the new legislation signed by the city’s Governor will also prohibit insurance companies from requiring a doctor’s certificate before covering the said drugs in their insurance coverage.

California has an estimated 30,000 people who are using PrEP as part of their HIV prevention management, and 6,000 people are using PEP to manage their HIV reactive status.

According to the medical analysis presented during the deliberation for the new legislation, PEP and PrEP are recognized by the medical community as effective preventive drugs for HIV-AIDS. The PrEP is taken by negative individuals to reduce the risk of transmission of the virus. On the other hand, PEP is effective in preventing the virus from taking hold when a person has already been exposed to HIV.

Advocates say that PEP is most effective when taken 72 days after exposure to HIV; however, during that timeline, patients usually don’t have access to a doctor. They say that the new law will make the drugs available to those who need it the most.

“The ability to go into a pharmacy to avail themselves of the medication is a huge improvement to removing the barrier,” Rick Zbur, the executive director of Equality California, said.

Furthermore, because of the opposition of the medical community, the initial draft of the law was revised to include a provision that limits the number of HIV prevention pills a person can purchase without a prescription.

“To end new HIV infections, we must dramatically expand access to PrEP and PEP, yet far too many Californians who need these drugs struggle to access them,” said Senator Scott Weiner, co-author of the bill and has publicly disclosed that he is using PrEP as part of his HIV prevention strategy.

Previous Post

Johnson & Johnson to pay $8B in damages to a man who ‘grew breasts’ after taking its drug

Next Post

Tim Cook: ‘HK protesters use HKmap.live app to target police’

PublicWire

At PublicWire, we know the vast majority of all investors conduct their due diligence and get their news online in a variety of ways including email, social media, financial websites, text messages, RSS feeds and audio/video podcasts. PublicWire’s financial communications program is uniquely positioned to reach these investors throughout the U.S. and Canada as well as on a global scale.

Related Posts

Medical

FDA advisory panel recommends Moderna, Johnson & Johnson vaccine booster shots

October 18, 2021
0
Medical

Walgreens invests $5.5B to accelerate new healthcare business segment

October 18, 2021
0
Medical

Mayo Clinic to study respiratory muscle training as long COVID treatment

October 18, 2021
0
Medical

Anthem, Providence tap Vim for value-based care platform deployment

October 25, 2021
0
Medical

Healthcare lost 17,500 jobs in September amid ongoing labor shortage

October 25, 2021
0
Medical

Cigna divests life, accident and supplemental benefits businesses for $5.75B

October 25, 2021
0
Next Post
Photo: Mike Deerkoski | Flickr | CC BY 2.0

Tim Cook: 'HK protesters use HKmap.live app to target police'

Please login to join discussion

Subscribe To Our Newsletter

Loading
Ad
PublicWire | Emerging Market Stock News 24/7 | Investor Relations US Stock Market

© Copyright 2022 publicwire.com

Navigate Site

  • About
  • Contact Us
  • Disclaimer
  • Watch LIVE
  • Privacy Policy
  • Terms and Services
  • Contributors

Follow Us

No Result
View All Result
  • LIVE Investor News Channel
  • Cannabis
  • Energy
  • Finance
  • General
  • Medical
  • Podcasts
  • Retail
  • Technology
  • Videos

© Copyright 2022 publicwire.com

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.